Table of Contents Table of Contents
Previous Page  90 / 112 Next Page
Information
Show Menu
Previous Page 90 / 112 Next Page
Page Background

88

NCCN Guidelines for Patients

®

Prostate Cancer, Version 1.2016

Review

• Advanced disease is often first treated with ADT.

• CRPC is prostate cancer that grows even though

testosterone is at very low levels.

• A clinical trial, observation, and secondary

hormone therapy are options for CRPC without

metastases.

• Newer treatments for CRPC with metastases

include sipuleucel-T, abiraterone acetate,

enzalutamide, and radium-223. Chemotherapy

with hormone therapy, clinical trials, and secondary

hormone therapy are other options.

• All men with CRPC should receive supportive care.

7

Treatment guide: Systemic treatment

Castration-recurrent prostate cancer